Menu

• Ask a Health Expert about ENDOMETRIAL CANCER METASTATIC
• Post Your Side Effect related to ENDOMETRIAL CANCER METASTATIC
• ENDOMETRIAL CANCER METASTATIC and FDA Warnings
• ENDOMETRIAL CANCER METASTATIC in Patients Wiki
• Report ENDOMETRIAL CANCER METASTATIC in Drug Side Effect Survey

ENDOMETRIAL CANCER METASTATIC side effect

What is ENDOMETRIAL CANCER METASTATIC ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Cenestin Side Effects Report #5379575-4
Consumer or non-health professional from JAPAN reported CENESTIN problem on May 21, 2007. Female patient, 40 years of age, was diagnosed with oestradiol decreased and was treated with CENESTIN. After drug was administered, patient experienced the following problems/side effects: endometrial cancer metastatic, lipid metabolism disorder, metastases to abdominal cavity, metastases to liver, metastases to lymph nodes, . CENESTIN dosage: 0.625 MG. During the same period patient was treated with MEDROXYPROGESTERONE. Patient died.

Cenestin Side Effects Report #5379575-4
CENESTIN problem was reported by a Consumer or non-health professional from JAPAN on May 21, 2007. Female patient, 40 years of age, was diagnosed with oestradiol decreased and was treated with CENESTIN. After drug was administered, patient experienced the following problems/side effects: endometrial cancer metastatic, lipid metabolism disorder, metastases to abdominal cavity, metastases to liver, metastases to lymph nodes, . CENESTIN dosage: 0.625 MG. During the same period patient was treated with MEDROXYPROGESTERONE. Patient died.

Cenestin Side Effects Report #5348249-8
Consumer or non-health professional from JAPAN reported CENESTIN problem on May 21, 2007. Female patient, 40 years of age, was diagnosed with oestradiol decreased and was treated with CENESTIN. After drug was administered, patient experienced the following problems/side effects: endometrial cancer metastatic, lipid metabolism disorder, metastases to liver, metastases to lymph nodes, suprapubic pain, vaginal haemorrhage, . CENESTIN dosage: 0.625 MG. During the same period patient was treated with MEDROXYPROGESTERONE ACETATE. Patient died.

Tamoxifen Side Effects Report #5375134-8
TAMOXIFEN CITRATE problem was reported by a Physician from UNITED STATES on Aug 22, 2006. Female patient, 54 years of age, was diagnosed with breast cancer stage iii and was treated with TAMOXIFEN CITRATE. After drug was administered, patient experienced the following problems/side effects: endometrial cancer metastatic, . TAMOXIFEN CITRATE dosage: unknown. Patient recovered.


Premarin Side Effects Report #5262614-9
Consumer or non-health professional from UNITED STATES reported PREMARIN problem on Mar 05, 2007. Female patient, 56 years of age, was diagnosed with vaginal relaxation, arthralgia and was treated with PREMARIN. After drug was administered, patient experienced the following problems/side effects: endometrial cancer metastatic, . PREMARIN dosage: unknown. During the same period patient was treated with IBUPROFEN. Patient recovered.